Budget 2026-27: Biopharma SHAKTI at ₹10,000 Crore; ₹20,000 Crore for CCUS in Heavy Industry
Biopharma SHAKTI at ₹10,000 cr for global biomanufacturing hub; ₹20,000 cr for CCUS in 5 industrial sectors.
pib.gov.in
Key Points for RAS
- Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) — ₹10,000 crore over 5 years for biomanufacturing hub
- Scheme supports domestic production of biologics and biosimilars targeting cancer, diabetes, and autoimmune disorders
- 3 new NIPERs to be established, 7 existing upgraded, and network of 1,000+ accredited clinical trial sites created
- ₹20,000 crore allocated for CCUS across 5 industrial sectors: power, steel, cement, refineries, and chemicals
- Nuclear energy received customs duty exemptions extended until 2035; private participation in small modular reactors opened
The Union Budget 2026-27 announced Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) with ₹10,000 crore outlay over five years to position India as a global biomanufacturing hub. The scheme will support domestic production of biologics and biosimilars targeting cancer, diabetes, and autoimmune disorders, establish 3 new NIPERs, upgrade 7 existing ones, and create a network of over 1,000 accredited clinical trial sites.
Separately, ₹20,000 crore was allocated for Carbon Capture, Utilization and Storage (CCUS) across five industrial sectors — power, steel, cement, refineries, and chemicals — aligned with the national CCUS roadmap released in December 2025 and India's Net Zero 2070 strategy. Nuclear energy received customs duty exemptions extended until 2035, with the door opened for private participation in small modular reactors.
Frequently Asked Questions
1 What is the Biopharma SHAKTI scheme announced in Union Budget 2026-27?
Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) was announced in Union Budget 2026-27 with a ₹10,000 crore outlay over 5 years. It targets domestic production of biologics and biosimilars for cancer, diabetes, and autoimmune disorders, establishing 3 new NIPERs, upgrading 7 existing ones, and creating a network of 1,000+ accredited clinical trial sites.
2 How much has Union Budget 2026-27 allocated for Carbon Capture (CCUS)?
The Union Budget 2026-27 allocated ₹20,000 crore for Carbon Capture, Utilization and Storage (CCUS) across 5 industrial sectors: power, steel, cement, refineries, and chemicals. This aligns with India national CCUS roadmap released in December 2025 and the Net Zero 2070 strategy.
3 What are the key objectives of the Biopharma SHAKTI scheme in Budget 2026-27?
Biopharma SHAKTI aims to position India as a global biomanufacturing hub by supporting domestic production of biologics; establishing 3 new NIPERs and upgrading 7 existing ones; creating 1,000+ accredited clinical trial sites; and strengthening CDSCO with a dedicated scientific review cadre to meet global approval timeframes.
4 What nuclear energy provisions were announced in Budget 2026-27?
Budget 2026-27 extended customs duty exemptions for nuclear energy until 2035 and opened the door for private participation in Small Modular Reactors (SMRs). The budget also allocated ₹20,000 crore for the Nuclear Energy Mission for SMR development, signaling a major shift toward clean energy diversification.
5 Which five industrial sectors are covered under CCUS funding in Budget 2026-27?
The ₹20,000 crore CCUS allocation in Budget 2026-27 covers: power, steel, cement, refineries, and chemicals. The funding is aligned with India national CCUS roadmap released in December 2025 and supports India commitment to achieve Net Zero by 2070.
Mains Exam Angle
Practice question with model answer for RAS Mains
Q: Evaluate Budget 2026-27's strategic allocations — Biopharma SHAKTI and CCUS — as drivers of India's health innovation and Net Zero 2070 commitment.
Answer (50 words):
Union Budget 2026-27 committed ₹10,000 crore over five years to Biopharma SHAKTI for biomanufacturing, establishing 3 new NIPERs and upgrading 7. ₹20,000 crore was allocated for CCUS across power, steel, cement, refineries and chemicals, aligned with India's Net Zero 2070 goal. Nuclear customs exemptions extended until 2035.
Related Past Year Questions
Nuclear energy roadmap announced in Union Budget 2025-26
Connection: Both concern Union Budget provisions for nuclear/energy transition; Budget 2026-27 extends nuclear customs exemption until 2035 and funds CCUS.
RPSC Syllabus Mapping
Monetary & Fiscal Policy
Indian Economy
Health, Food & Nutrition
Science & Technology